摘要:
sci-hub.st 参考文章(415)
Maurizia Rossana Brunetto, Francesco Moriconi, Ferruccio Bonino, George K. K. Lau, Patrizia Farci, Cihan Yurdaydin, Teerha Piratvisuth, Kangxian Luo, Yuming Wang, Stephanos Hadziyannis, Eva Wolf, Philip McCloud, Richard Batrla, Patrick Marcellin, Hepatitis B virus surface antigen levels: A guide to sustained response to peginterferon alfa‐2a in HBeAg‐negative chronic hepatitis B Hepatology. ,vol. 49, pp. 1141- 1150 ,(2009) , 10.1002/HEP.22760
L. M. M. Wolters, A. B. van Nunen, P. Honkoop, A. C. T. M. Vossen, H. G. M. Niesters, P. E. Zondervan, R. A. de Man, Lamivudine-high dose interferon combination therapy for chronic hepatitis B patients co-infected with the hepatitis D virus. Journal of Viral Hepatitis. ,vol. 7, pp. 428- 434 ,(2000) , 10.1046/J.1365-2893.2000.00254.X
Mauricio Lisker-Melman, David Webb, Adrian M Di Bisceglie, Chris Kassianides, Paul Martin, Vinod Rustgi, Jeanne G Waggoner, Yoon Park, Jay H Hoofnagle, None, Glomerulonephritis Caused by Chronic Hepatitis B Virus Infection: Treatment with Recombinant Human Alpha-Interferon Annals of Internal Medicine. ,vol. 111, pp. 479- 483 ,(1989) , 10.7326/0003-4819-111-6-479
Luisa Benvegnù, Giovanna Fattovich, Franco Noventa, Federico Tremolada, Liliana Chemello, Attilio Cecchetto, Alfredo Alberti, None, Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. A prospective study. Cancer. ,vol. 74, pp. 2442- 2448 ,(1994) , 10.1002/1097-0142(19941101)74:9<2442::AID-CNCR2820740909>3.0.CO;2-#
J. L. Casey, T. L. Brown, E. J. Colan, F. S. Wignall, J. L. Gerin, A genotype of hepatitis D virus that occurs in northern South America. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 90, pp. 9016- 9020 ,(1993) , 10.1073/PNAS.90.19.9016
Marc G. Ghany, Brick Ayola, Federico G. Villamil, Robert G. Gish, Sergio Rojter, John M. Vierling, Anna S. Lok, Hepatitis B virus S mutants in liver transplant recipients who were reinfected despite hepatitis B immune globulin prophylaxis. Hepatology. ,vol. 27, pp. 213- 222 ,(1998) , 10.1002/HEP.510270133
FL Connor, AR Rosenberg, SE Kennedy, TD Bohane, HBV associated nephrotic syndrome: resolution with oral lamivudine Archives of Disease in Childhood. ,vol. 88, pp. 446- 449 ,(2003) , 10.1136/ADC.88.5.446
Dr. Vito Di Marco, Alfredo Marzano, Pietro Lampertico, Pietro Andreone, Teresa Santantonio, Piero Luigi Almasio, Mario Rizzetto, Antonio Craxì, Clinical outcome of HBeAg‐negative chronic hepatitis B in relation to virological response to lamivudine Hepatology. ,vol. 40, pp. 883- 891 ,(2004) , 10.1002/HEP.1840400418
Ming-Hua Zheng, Ke-Qing Shi, Zhi-Juan Dai, Chao Ye, Yong-Ping Chen, A 24-week, parallel-group, open-label, randomized clinical trial comparing the early antiviral efficacy of telbivudine and entecavir in the treatment of hepatitis B e antigen-positive chronic hepatitis B virus infection in adult Chinese patients Clinical Therapeutics. ,vol. 32, pp. 649- 658 ,(2010) , 10.1016/J.CLINTHERA.2010.04.001
Christian Pagnoux, Raphaèle Seror, Corneliu Henegar, Alfred Mahr, Pascal Cohen, Véronique Le Guern, Boris Bienvenu, Luc Mouthon, Loïc Guillevin, , Clinical features and outcomes in 348 patients with polyarteritis nodosa: a systematic retrospective study of patients diagnosed between 1963 and 2005 and entered into the French Vasculitis Study Group Database Arthritis & Rheumatism. ,vol. 62, pp. 616- 626 ,(2010) , 10.1002/ART.27240